Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: A literature review

International Journal of Antimicrobial Agents

Volumn 41, Issue 6, 2013, Pages 499-508

  Karaiskos, Ilias ^a   Galani, Lambrini ^a   Baziaka, Fotini ^a   Giamarellou, Helen ^a  

^a IASO GENERAL HOSPITAL   (Greece)

Author keywords

Acinetobacter; Colistin; Intrathecal; Intraventricular; MDR strains; Meningitis; Ventriculitis; XDR strains

Indexed keywords

COLISTIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ASEPSIS; BACTERIAL STRAIN; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID; CHEMICAL MENINGITIS; CHEMICAL VENTRICULITIS; CHILD HEALTH CARE; DRUG SAFETY; EXTENSIVELY RESISTANT ACINETOBACTER BAUMANNII INFECTION; HUMAN; MENINGITIS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT ACINETOBACTER BAUMANNII INFECTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84877701972     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.02.006     Document Type: Short Survey

References (61)

1. H. Giamarellou, A. Antoniadou, and K. Kanellakopoulou Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 32 2008 106 119
2. S. Navon-Venezia, R. Ben-Ami, and Y. Carmeli Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting Curr Opin Infect Dis 18 2005 306 313
3. P.E. Fournier, D. Vallenet, V. Barbe, S. Audic, H. Ogata, and L. Poirel Comparative genomics of multidrug resistance in Acinetobacter baumannii PLoS Genet 2 2006 e7
4. H. Giamarellou, and G. Poulakou Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 69 2009 1879 1901
5. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, and C.G. Giske Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268 281
6. S.L. Markantonis, N. Markou, M. Fousteri, N. Sakellaridis, S. Karatzas, and I. Alamanos Penetration of colistin into cerebrospinal fluid Antimicrob Agents Chemother 53 2009 4907 4910
7. C. Antachopoulos, M. Karvanen, E. Iosifidis, B. Jansson, D. Plachouras, and O. Cars Serum and cerebrospinal fluid levels of colistin in pediatric patients Antimicrob Agents Chemother 54 2010 3985 3987
8. S.L. Kaplan, and C.C. Patrick Cefotaxime and aminoglycoside treatment of meningitis caused by Gram-negative enteric organisms Pediatr Infect Dis J 9 1990 810 814
9. P. Fernandez-Viladrich, X. Corbella, L. Corral, F. Tubau, and A. Mateu Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium Clin Infect Dis 28 1999 916 917
10. W. Vasen, P. Desmery, S. Ilutovich, and A. Di Martino Intrathecal use of colistin J Clin Microbiol 38 2000 3523
11. M. Benifla, G. Zucker, A. Cohen, and M. Alkan Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E J Antimicrob Chemother 54 2004 290 292
12. H. Sueke, H. Marsh, and A. Dhital Using intrathecal colistin for multidrug resistant shunt infection Br J Neurosurg 19 2005 51 52
13. Z. Bukhary, W. Mahmood, A. Al-Khani, and H.M. Al-Abdely Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin Saudi Med J 26 2005 656 658
14. S.K. Kasiakou, P.I. Rafailidis, K. Liaropoulos, and M.E. Falagas Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin J Infect 50 2005 348 352
15. D. Berlana, J.M. Llop, E. Fort, M.B. Badia, and R. Jodar Use of colistin in the treatment of multiple-drug-resistant Gram-negative infections Am J Health Syst Pharm 62 2005 39 47
16. B. Charra, A. Hachimi, A. Benslama, and S. Motaouakkil Intrathecal use of colistin Ann Fr Anesth Reanim 25 2006 215 [in French]
17. J. Ng, I.B. Gosbell, J.A. Kelly, M.J. Boyle, and J.K. Ferguson Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review J Antimicrob Chemother 58 2006 1078 1081
18. N. Al Shirawi, Z.A. Memish, A. Cherfan, and A. Al Shimemeri Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumannii treated with intrathecal colistin: case report and review of the literature J Chemother 18 2006 554 558
19. S. Motaouakkil, B. Charra, A. Hachimi, H. Nejmi, A. Benslama, and N. Elmdaghri Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii J Infect 53 2006 274 278
20. D. Karakitsos, E. Paramythiotou, G. Samonis, and A. Karabinis Is intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit? Acta Anaesthesiol Scand 50 2006 1309 1310
21. E. Paramythiotou, D. Karakitsos, H. Aggelopoulou, P. Sioutos, G. Samonis, and A. Karabinis Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas Med Mal Infect 37 2007 124 125
22. Y.H. Ho, L.S. Wang, H.J. Chao, K.C. Chang, and C.F. Su Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin J Microbiol Immunol Infect 40 2007 537 540
23. G. Metan, E. Alp, B. Aygen, and B. Sumerkan Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance J Antimicrob Chemother 60 2007 197 199
24. A. Rodríguez Guardado, A. Blanco, V. Asensi, F. Pérez, J.C. Rial, and V. Pintado Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments J Antimicrob Chemother 61 2008 908 913
25. C.H. Lee, Y.F. Tang, L.H. Su, C.C. Chien, and J.W. Liu Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia Microb Drug Resist 14 2008 233 237
26. A. Hachimi, B. Charra, A. Benslama, and S. Motaouakkil Intrathecal use of amikacin and colistin Ann Fr Anesth Reanim 27 2008 113 114 [in French]
27. S.H. Sabin, A. Selik, and D. Memis Intrathecal colistin for treatment of Acinetobacter spp meningitis: case report Internet J Infect Dis 6 2008 10.5580/1708
28. C.H. Rodriguez, K. Bombicino, G. Granados, M. Nastro, C. Vay, and A. Famiglietti Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin Diagn Microbiol Infect Dis 65 2009 188 191
29. N. Dalgic, Y. Ceylan, M. Sancar, L. Telhan, I. Kafadar, and H. Cavusoglu Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin Ann Trop Paediatr 29 2009 141 147
30. B. López-Alvarez, R. Martín-Láez, M.C. Fariñas, B. Paternina-Vidal, J.D. García-Palomo, and A. Vázquez-Barquero Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin Acta Neurochir (Wien) 151 2009 1465 1472
31. A. Cascio, A. Conti, L. Sinardi, C. Iaria, F.F. Angileri, and G. Stassi Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature Int J Infect Dis 14 2010 e572 e579
32. T. Khawcharoenporn, A. Apisarnthanarak, and L.M. Mundy Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review Clin Microbiol Infect 16 2010 888 894
33. G. De Pascale, A. Pompucci, R. Maviglia, T. Spanu, G. Bello, and A. Mangiola Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin Minerva Anestesiol 76 2010 957 960
34. H. Özdemir, A. Tapisiz, E. Ciftçi, E. Ince, H. Mokhtari, and H. Güriz Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis Infection 38 2010 241 244
35. K. Kim, H.S. Kang, C.H. Sohn, and B.M. Oh Cauda equina syndrome misdiagnosed as aggravated hydrocephalus: neurological complication of intrathecal colistin in post-surgical meningitis Acta Neurochir (Wien) 153 2011 425 427
36. A. Razmkon, A. Mehrafshan, and A. Bakhtazad Management of post-neurosurgical Acinetobacter infections: experiences obtained during an outbreak Acta Neurochir (Wien) 153 2011 435 436
37. J.A. Patel, S.M. Pacheco, M. Postelnick, and S. Sutton Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis Am J Health Syst Pharm 68 2011 1527 1531
38. A.F. Saleem, M.S. Shah, A.S. Shaikh, F. Mir, and A.K. Zaidi Acinetobacter species meningitis in children: a case series from Karachi, Pakistan J Infect Dev Ctries 5 2011 809 814
39. S.Y. Alaoui, S.E. Nejmi, A.A. Chakir, B. Hmamouchi, and A. Chlilek Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumannii Ann Fr Anesth Reanim 30 2011 854 855 [in French]
40. R. Imberti, M. Cusato, G. Accetta, V. Marinò, F. Procaccio, and A. Del Gaudio Cerebrospinal fluid pharmacokinetics of colistin after intraventricular administration of colistin methanesulfonate Antimicrob Agents Chemother 56 2012 4416 4421
41. J.H. Wang, P.C. Lin, C.H. Chou, C.M. Ho, K.H. Lin, and C.T. Tsai Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study J Microbiol Immunol Infect 2012 10.1016/j.jmii.2012.08.028 [Epub ahead of print]
42. Z. Mairi, S.L. Markantonis, F. Marizoza, Z. Paris, D. Panidis, and K. Marios Combined intravenous and intraventricular administration of colistin methane sulphonate in critically ill patients with CNS infection Antimicrob Agents Chemother 2013 10.1128/AAC.01461-12 [Epub ahead of print]
43. Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, et al. Successful treatment of extensively drug-resistant (XDR) Acinetobacter baumannii meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents, http://dx.doi.org/10.1016/ j.ijantimicag.2013.02.010.
44. S. Sacar, H. Turgut, S. Toprak, B. Cirak, E. Coskun, and O. Yilmaz A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period BMC Infect Dis 6 2006 43
45. G. Metan, E. Alp, B. Aygen, and B. Sumerkan Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis Int J Antimicrob Agents 29 2007 112 113
46. H.I. Kim, S.W. Kim, G.Y. Park, E.G. Kwon, H.H. Kim, and J.Y. Jeong The causes and treatment outcomes of 91 patients with adult nosocomial meningitis Korean J Intern Med 27 2012 171 179
47. B.N. Kim, A.Y. Peleg, T.P. Lodise, J. Lipman, J. Li, and R. Nation Management of meningitis due to antibiotic-resistant Acinetobacter species Lancet Infect Dis 9 2009 245 255
48. A. Michalopoulos, and M.E. Falagas Treatment of Acinetobacter infections Expert Opin Pharmacother 11 2010 779 788
49. A.R. Tunkel, B.J. Hartman, S.L. Kaplan, B.A. Kaufman, K.L. Roos, and W.M. Scheld Practice guidelines for the management of bacterial meningitis Clin Infect Dis 39 2004 1267 1284
50. J. Garnacho-Montero, and R. Amaya-Villar Multiresistant Acinetobacter baumannii infections: epidemiology and management Curr Opin Infect Dis 23 2010 332 339
51. D. Plachouras, M. Karvanen, L.E. Friberg, E. Papadomichelakis, A. Antoniadou, and I. Tsangaris Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria Antimicrob Agents Chemother 53 2009 3430 3436
52. M.E. Falagas, I.A. Bliziotis, and V.H. Tam Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence Int J Antimicrob Agents 29 2007 9 25
53. L. Ray, K. Levasseur, D.P. Nicolau, and M.H. Scheetz Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritis Ann Pharmacother 44 2010 582 586
54. E.E. Tutuncu, F. Kuscu, Y. Gurbuz, B. Ozturk, A. Haykir, and I. Sencan Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis Int J Infect Dis 14 Suppl. 3 2010 e224 e226
55. E.J. Giamarellos-Bourboulis, E. Xirouchaki, and H. Giamarellou Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii Diagn Microbiol Infect Dis 40 2001 117 120
56. A. Pantopoulou, E.J. Giamarellos-Bourboulis, M. Raftogannis, T. Tsaganos, I. Dontas, and P. Koutoukas Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin Int J Antimicrob Agents 29 2007 51 55
57. J. Vila, and J. Pachón Acinetobacter baumannii resistant to everything: what should we do? Clin Microbiol Infect 17 2011 955 956
58. R. Beer, P. Lackner, B. Pfausler, and E. Schmutzhard Nosocomial ventriculitis and meningitis in neurocritical care patients J Neurol 255 2008 1617 1624
59. M. Al-Dabbagh, and S. Dobson Management of shunt related infections Adv Exp Med Biol 719 2011 105 115
60. S. Laxmi, and A.R. Tunkel Healthcare-associated bacterial meningitis Curr Infect Dis Rep 13 2011 367 373
61. J. Rodríguez-Baño, S. Martí, S. Soto, F. Fernández-Cuenca, J.M. Cisneros, and J. Pachón Biofilm formation in Acinetobacter baumannii: associated features and clinical implications Clin Microbiol Infect 14 2008 276 278